Cutler Group LP Immunocore Holdings PLC Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 19, 2024
BUY
$60.14 - $75.36 $102,238 - $128,112
1,700 Added 62.96%
4,400 $4,000
Q4 2023

Jan 18, 2024
BUY
$42.85 - $69.5 $81,415 - $132,050
1,900 Added 237.5%
2,700 $23,000
Q3 2023

Nov 07, 2023
SELL
$49.5 - $66.6 $34,650 - $46,619
-700 Reduced 46.67%
800 $1,000
Q2 2023

Jul 18, 2023
BUY
$48.54 - $61.64 $72,810 - $92,460
1,500 New
1,500 $3,000

Others Institutions Holding IMCR

# of Institutions
140
Shares Held
40.8M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.26B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email